{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:11:18Z","timestamp":1787847078801,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to determine the current corticosteroid use and bone health management status of patients with Duchenne muscular dystrophy (DMD) in South Korea. This is a national population-based study utilized information from the databased of Korean National Health Insurance Database. Database regarding bone status, spine radiography findings, bone mineral density, and laboratory test results were obtained, as well as the proportion of patients with spine and lower limb prostheses, occurrence of scoliosis, and age at scoliosis surgery. Deflazacort dose in the ambulant group (aged\u2009&lt;\u200915\u00a0years) increased by age and year. The maintenance dose of prednisolone and deflazacort for the 15\u201319\u00a0years group decreased by year. Among the patients, 12.47% underwent spine radiography, 23.11% underwent dual-energy X-ray absorptiometry, and 22.7% underwent vitamin D tests. Moreover, 40.9% of the patients were prescribed vitamin D at a mean age of 14.6\u2009\u00b1\u20096.1\u00a0years, while 10.22% were prescribed bisphosphonate at 17.92\u2009\u00b1\u20093.4\u00a0years. Further, 16.1% of the patients underwent posterior spinal instrumentation and fusion at 14.4\u2009\u00b1\u20092.3\u00a0years and 5.3% underwent anterior spinal instrumentation and fusion at 14.4\u2009\u00b1\u20092.3\u00a0years. Ankle\u2013foot orthosis and spine orthosis prescriptions were noted in 4.91% and 1.84% of patients, respectively. In this our study, the current corticosteroid use and bone health management status of DMD in South Korea has been presented. The dose prescription for corticosteroid and bone health monitoring did not reach to current recommendation.<\/jats:p>","DOI":"10.1038\/s41598-022-15510-1","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T16:03:30Z","timestamp":1656950610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Corticosteroid use and bone health management for Duchenne muscular dystrophy in South Korea"],"prefix":"10.1038","volume":"12","author":[{"given":"Jin A","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungmin","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Beom","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"key":"15510_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.23528","volume":"71","author":"JR Mendell","year":"2012","unstructured":"Mendell, J. R. et al. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann. Neurol. 71, 304\u2013313 (2012).","journal-title":"Ann. Neurol."},{"key":"15510_CR2","first-page":"438","volume":"44","author":"YC Choi","year":"2007","unstructured":"Choi, Y. C., Kang, D. R. & Kim, D. S. Nationwide survey of muscular dystrophy in Korea. Rep. Natl. Inst. Health. 44, 438\u2013441 (2007).","journal-title":"Rep. Natl. Inst. Health."},{"key":"15510_CR3","first-page":"123","volume-title":"Muscular Dystrophy 1976","author":"PJ Vignos","year":"1977","unstructured":"Vignos, P. J. Respiratory function and pulmonary infection in Duchenne muscular dystrophy. In Muscular Dystrophy 1976 (eds Robin, G. C. & Falewski de Leon, G.) 123\u2013130 (Karger Publishers, 1977)."},{"key":"15510_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","volume":"26","author":"G Nigro","year":"1990","unstructured":"Nigro, G., Comi, L. I., Politano, L. & Bain, R. J. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int. J. Cardiol. 26, 271\u2013277 (1990).","journal-title":"Int. J. Cardiol."},{"key":"15510_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.4187\/respcare.00831","volume":"56","author":"JR Bach","year":"2011","unstructured":"Bach, J. R. & Martinez, D. Duchenne muscular dystrophy: Continuous noninvasive ventilatory support prolongs survival. Respir. Care. 56, 744\u2013750 (2011).","journal-title":"Respir. Care."},{"key":"15510_CR6","first-page":"121","volume":"31","author":"L Passamano","year":"2012","unstructured":"Passamano, L. et al. Improvement of survival in Duchenne muscular dystrophy: Retrospective analysis of 835 patients. Acta Myol. 31, 121\u2013125 (2012).","journal-title":"Acta Myol."},{"key":"15510_CR7","doi-asserted-by":"crossref","unstructured":"Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst. Rev. CD003725 (2016).","DOI":"10.1002\/14651858.CD003725.pub4"},{"key":"15510_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby, K. et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 9, 77\u201393 (2010).","journal-title":"Lancet Neurol."},{"key":"15510_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby, K. et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: Implementation of multidisciplinary care. Lancet Neurol. 9, 177\u2013189 (2010).","journal-title":"Lancet Neurol."},{"key":"15510_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant, D. J. et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: Respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 17, 347\u2013361 (2018).","journal-title":"Lancet Neurol."},{"key":"15510_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.braindev.2019.12.005","volume":"42","author":"F Takeuchi","year":"2020","unstructured":"Takeuchi, F. et al. Clinical practice with steroid therapy for Duchenne muscular dystrophy: An expert survey in Asia and Oceania. Brain Dev. 42, 277\u2013288 (2020).","journal-title":"Brain Dev."},{"key":"15510_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant, D. J. et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 17, 251\u2013267 (2018).","journal-title":"Lancet Neurol."},{"key":"15510_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10654-020-00613-8","volume":"35","author":"E Landfeldt","year":"2020","unstructured":"Landfeldt, E. et al. Life expectancy at birth in Duchenne muscular dystrophy: A systematic review and meta-analysis. Eur. J. Epidemiol. 35, 643\u2013653 (2020).","journal-title":"Eur. J. Epidemiol."},{"key":"15510_CR14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","volume":"86","author":"D Gloss","year":"2016","unstructured":"Gloss, D., Moxley, R. T., Ashwal, S. & Oskoui, M. Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 86, 465\u2013472 (2016).","journal-title":"Neurology"},{"key":"15510_CR15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/mus.23272","volume":"45","author":"L Merlini","year":"2012","unstructured":"Merlini, L. et al. Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up. Muscle Nerve 45, 796\u2013802 (2012).","journal-title":"Muscle Nerve"},{"key":"15510_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jpeds.2016.02.067","volume":"173","author":"MM Lamb","year":"2016","unstructured":"Lamb, M. M. et al. Corticosteroid treatment and growth patterns in ambulatory males with Duchenne muscular dystrophy. J. Pediatr. 173, 207\u2013213 (2016).","journal-title":"J. Pediatr."},{"key":"15510_CR17","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1177\/0883073810371004","volume":"25","author":"RT Moxley 3rd","year":"2010","unstructured":"Moxley, R. T. 3rd., Pandya, S., Ciafaloni, E., Fox, D. J. & Campbell, K. Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: Implications for management. J. Child Neurol. 25, 1116\u20131129 (2010).","journal-title":"J. Child Neurol."},{"key":"15510_CR18","doi-asserted-by":"crossref","unstructured":"Manzur AY, Kuntzer T, Pike M, Swan AV. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst. Rev. CD003725 (2008).","DOI":"10.1002\/14651858.CD003725.pub3"},{"key":"15510_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cct.2017.04.008","volume":"58","author":"M Guglieri","year":"2017","unstructured":"Guglieri, M. et al. Developing standardized corticosteroid treatment for Duchenne muscular dystrophy. Contemp. Clin Trials. 58, 34\u201339 (2017).","journal-title":"Contemp. Clin Trials."},{"key":"15510_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-019-1304-8","volume":"19","author":"L Cowen","year":"2019","unstructured":"Cowen, L., Mancini, M., Martin, A., Lucas, A. & Donovan, J. M. Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry. BMC Neurol. 19, 1\u201310 (2019).","journal-title":"BMC Neurol."},{"key":"15510_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/01241398-200001000-00016","volume":"20","author":"CM Larson","year":"2000","unstructured":"Larson, C. M. & Henderson, R. C. Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J. Pediatr. Orthop. 20, 71\u201374 (2000).","journal-title":"J. Pediatr. Orthop."},{"key":"15510_CR22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/01241398-199307000-00012","volume":"13","author":"T Oda","year":"1993","unstructured":"Oda, T. et al. Longitudinal study of spinal deformity in Duchenne muscular dystrophy. J. Pediatr. Orthop. 13, 478\u2013488 (1993).","journal-title":"J. Pediatr. Orthop."},{"key":"15510_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12891-019-2661-6","volume":"20","author":"Y-A Choi","year":"2019","unstructured":"Choi, Y.-A., Shin, H.-I. & Shin, H. I. Scoliosis in Duchenne muscular dystrophy children is fully reducible in the initial stage, and becomes structural over time. BMC Musculoskelet. Disord. 20, 277 (2019).","journal-title":"BMC Musculoskelet. Disord."},{"key":"15510_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2106\/JBJS.M.00777","volume":"96","author":"KS Suk","year":"2014","unstructured":"Suk, K. S. et al. Functional outcomes in Duchenne muscular dystrophy scoliosis: Comparison of the differences between surgical and nonsurgical treatment. J. Bone Joint Surg. Am. 96, 409\u2013415 (2014).","journal-title":"J. Bone Joint Surg. Am."},{"key":"15510_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.21037\/jss.2016.08.05","volume":"2","author":"JE Archer","year":"2016","unstructured":"Archer, J. E., Gardner, A. C., Roper, H. P., Chikermane, A. A. & Tatman, A. J. Duchenne muscular dystrophy: The management of scoliosis. J. Spine Surg. 2, 185\u2013194 (2016).","journal-title":"J. Spine Surg."},{"key":"15510_CR26","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1212\/01.wnl.0000260974.41514.83","volume":"68","author":"W King","year":"2007","unstructured":"King, W. et al. Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology 68, 1607\u20131613 (2007).","journal-title":"Neurology"},{"key":"15510_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3233\/JND-170280","volume":"4","author":"Z Koeks","year":"2017","unstructured":"Koeks, Z. et al. Clinical outcomes in Duchenne muscular dystrophy: A study of 5345 patients from the TREAT-NMD DMD global database. J. Neuromusc. Dis. 4, 293\u2013306 (2017).","journal-title":"J. Neuromusc. Dis."},{"issue":"18","key":"15510_CR28","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1097\/00007632-200209150-00020","volume":"27","author":"DK Sengupta","year":"2002","unstructured":"Sengupta, D. K., Mehdian, S., McConnell, J. R., Eisenstein, S. M. & Webb, J. K. Pelvic or lumbar fixation for the surgical management of scoliosis in Duchenne muscular dystrophy. Spine 27(18), 2072\u20132079 (2002).","journal-title":"Spine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15510-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15510-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15510-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T06:12:04Z","timestamp":1669356724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15510-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15510"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15510-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,4]]},"assertion":[{"value":"14 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11300"}}